This Week in PLoS

In PLoS One this week, a research team led by investigators at the University of Maryland School of Medicine show that polymorphisms of CYP19A1, a gene that encodes aromatase, "are associated with survival among patients with cardiovascular disease in a sex-specific manner." In case-control studies, the Maryland-led team genotyped participants for six CYP19A1 SNPs. For one SNP in particular — -81371 C — the team observed a 78 percent increase in mortality for men with acute coronary syndrome, as compared with affected women. The authors say that theirs is the first "study ...

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.